Akari Therapeutics PLC logo

Akari Therapeutics PLC - ADR

NEW
STU:CLA1 (USA)   ADR
€ 134.4 (0%) Sep 4
N/A
P/B:
1.08
Market Cap:
€ 262.08M ($ 304.26M)
Enterprise V:
€ 256.05M ($ 297.26M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Akari Therapeutics PLC Valuation Measures